These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 17952635)
1. Structure analysis of activity-dependent neurotrophic factor 9 by circular dichroism and sedimentation equilibrium. Arakawa T; Niikura T; Tajima H; Arisaka F; Kita Y J Mol Neurosci; 2007; 33(3):262-7. PubMed ID: 17952635 [TBL] [Abstract][Full Text] [Related]
2. Activity-dependent neurotrophic factor, ADNF, determines the structure characteristics of Colivelin, a fusion protein of ADNF9 and Humanin analog. Arakawa T; Niikura T; Arisaka F; Kita Y J Pept Sci; 2008 May; 14(5):631-6. PubMed ID: 17994638 [TBL] [Abstract][Full Text] [Related]
3. Short neuroprotective peptides, ADNF9 and NAP, are structurally disordered and monomeric in PBS. Arakawa T; Niikura T; Arisaka F; Kita Y Int J Biol Macromol; 2009 Jul; 45(1):8-11. PubMed ID: 19447252 [TBL] [Abstract][Full Text] [Related]
4. Active form of neuroprotective Humanin, HN, and inactive analog, S7A-HN, are monomeric and disordered in aqueous phosphate solution at pH 6.0; No correlation of solution structure with activity. Arisaka F; Arakawa T; Niikura T; Kita Y Protein Pept Lett; 2009; 16(2):132-7. PubMed ID: 19200035 [TBL] [Abstract][Full Text] [Related]
6. Antiserum to activity-dependent neurotrophic factor produces neuronal cell death in CNS cultures: immunological and biological specificity. Gozes I; Davidson A; Gozes Y; Mascolo R; Barth R; Warren D; Hauser J; Brenneman DE Brain Res Dev Brain Res; 1997 Apr; 99(2):167-75. PubMed ID: 9125470 [TBL] [Abstract][Full Text] [Related]
7. Neuroprotective effect of activity-dependent neurotrophic factor against toxicity from familial amyotrophic lateral sclerosis-linked mutant SOD1 in vitro and in vivo. Chiba T; Hashimoto Y; Tajima H; Yamada M; Kato R; Niikura T; Terashita K; Schulman H; Aiso S; Kita Y; Matsuoka M; Nishimoto I J Neurosci Res; 2004 Nov; 78(4):542-52. PubMed ID: 15478191 [TBL] [Abstract][Full Text] [Related]
8. The structure analysis of Humanin analog, AGA-(C8R)HNG17, by circular dichroism and sedimentation equilibrium: comparison with the parent molecule. Arisaka F; Niikura T; Arakawa T; Kita Y Int J Biol Macromol; 2008 Aug; 43(2):88-93. PubMed ID: 18456318 [TBL] [Abstract][Full Text] [Related]
9. NAP and D-SAL: neuroprotection against the beta amyloid peptide (1-42). Gozes I; Divinski I; Piltzer I BMC Neurosci; 2008 Dec; 9 Suppl 3(Suppl 3):S3. PubMed ID: 19091000 [TBL] [Abstract][Full Text] [Related]
12. Neurotrophic effects of the peptide NAP: a novel neuroprotective drug candidate. Gozes I; Spivak-Pohis I Curr Alzheimer Res; 2006 Jul; 3(3):197-9. PubMed ID: 16842095 [TBL] [Abstract][Full Text] [Related]
13. A femtomolar-acting neuroprotective peptide induces increased levels of heat shock protein 60 in rat cortical neurons: a potential neuroprotective mechanism. Zamostiano R; Pinhasov A; Bassan M; Perl O; Steingart RA; Atlas R; Brenneman DE; Gozes I Neurosci Lett; 1999 Apr; 264(1-3):9-12. PubMed ID: 10320001 [TBL] [Abstract][Full Text] [Related]
14. The secondary structure analysis of a potent Ser14Gly analog of antiAlzheimer peptide, Humanin, by circular dichroism. Arakawa T; Niikura T; Tajima H; Kita Y J Pept Sci; 2006 Oct; 12(10):639-42. PubMed ID: 16835886 [TBL] [Abstract][Full Text] [Related]
15. Somatostatin conformation: evidence for a stable intramolecular structure from circular dichroism, diffusion, and sedimentation equilibrium. Holladay LA; Puett D Proc Natl Acad Sci U S A; 1976 Apr; 73(4):1199-202. PubMed ID: 1063402 [TBL] [Abstract][Full Text] [Related]
16. HIV-1 membrane fusion mechanism: structural studies of the interactions between biologically-active peptides from gp41. Lawless MK; Barney S; Guthrie KI; Bucy TB; Petteway SR; Merutka G Biochemistry; 1996 Oct; 35(42):13697-708. PubMed ID: 8885850 [TBL] [Abstract][Full Text] [Related]
17. Cholesteryl-functionalized ADNF-9 peptide: enhanced membrane transport through mouse neuroblastoma Neuro-2a cells. Katsari E; Zikos C; Tziveleka LA; Paravatou-Petsotas M; Paleos CM Chem Biol Drug Des; 2012 Jul; 80(1):148-54. PubMed ID: 22416980 [TBL] [Abstract][Full Text] [Related]
18. A new concept in the pharmacology of neuroprotection. Gozes I; Brenneman DE J Mol Neurosci; 2000; 14(1-2):61-8. PubMed ID: 10854037 [TBL] [Abstract][Full Text] [Related]
19. Design and characterization of an intramolecular antiparallel coiled coil peptide. Myszka DG; Chaiken IM Biochemistry; 1994 Mar; 33(9):2363-72. PubMed ID: 8117695 [TBL] [Abstract][Full Text] [Related]
20. Complete sequence of a novel protein containing a femtomolar-activity-dependent neuroprotective peptide. Bassan M; Zamostiano R; Davidson A; Pinhasov A; Giladi E; Perl O; Bassan H; Blat C; Gibney G; Glazner G; Brenneman DE; Gozes I J Neurochem; 1999 Mar; 72(3):1283-93. PubMed ID: 10037502 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]